Q BioMed Cash Flow Statement

Financials in millions USD. Fiscal year is December - November.

Millions USD. Fiscal year is Dec - Nov.

Year	2022	2021	2020	2019	2018	2017 - 2014
Net Income	-0.72	-8.75	-13.79	-11.74	-9.27	Upgrade
Depreciation & Amortization	0.05	0.05	0.05	0.05	0	Upgrade
Share-Based Compensation	0.9	2.34	6.57	2.5	0	Upgrade
Other Operating Activities	1.7	2.06	0.93	5.09	2.82	Upgrade
Operating Cash Flow	1.94	-4.3	-6.23	-4.11	-6.45	Upgrade
Capital Expenditures	0	0	0	0	-0.5	Upgrade
Change in Investments	-3.14	-	-	-	-	Upgrade
Investing Cash Flow	-3.14	0	0	0	-0.5	Upgrade
Common Stock Issued	0.12	1.01	0.32	0.62	4.95	Upgrade
Share Repurchases	0	0	-1.97	0	0	Upgrade
Other Financing Activities	0.79	3.46	3.95	0.97	3.87	Upgrade
Financing Cash Flow	0.91	4.47	6.24	1.59	8.81	Upgrade
Net Cash Flow	-0.29	0.17	0	-2.51	1.86	Upgrade
Free Cash Flow	1.94	-4.3	-6.23	-4.11	-6.95	Upgrade
Free Cash Flow Margin	682.75%	-2199.44%	-20778.14%	-	-	Upgrade
Free Cash Flow Per Share	0.04	-0.16	-0.28	-0.27	-0.51	Upgrade

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.